100 related articles for article (PubMed ID: 9550561)
1. Exon 5 of the p53 gene is a target for deletions in ovarian cancer.
Angelopoulou K; Levesque MA; Katsaros D; Shipman R; Diamandis EP
Clin Chem; 1998 Jan; 44(1):72-7. PubMed ID: 9550561
[TBL] [Abstract][Full Text] [Related]
2. Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: application to breast and ovarian tumors.
Angelopoulou K; Diamandis EP
J Clin Lab Anal; 1998; 12(4):250-6. PubMed ID: 9671178
[TBL] [Abstract][Full Text] [Related]
3. Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines.
Runnebaum IB; Tong XW; Moebus V; Heilmann V; Kieback DG; Kreienberg R
Hum Genet; 1994 Jun; 93(6):620-4. PubMed ID: 8005584
[TBL] [Abstract][Full Text] [Related]
4. High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic.
Vasickova P; Machackova E; Lukesova M; Damborsky J; Horky O; Pavlu H; Kuklova J; Kosinova V; Navratilova M; Foretova L
BMC Med Genet; 2007 Jun; 8():32. PubMed ID: 17561994
[TBL] [Abstract][Full Text] [Related]
5. Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma.
Kim JW; Cho YH; Kwon DJ; Kim TE; Park TC; Lee JM; Namkoong SE
Gynecol Oncol; 1995 May; 57(2):199-204. PubMed ID: 7729734
[TBL] [Abstract][Full Text] [Related]
6. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.
Okamoto A; Sameshima Y; Yokoyama S; Terashima Y; Sugimura T; Terada M; Yokota J
Cancer Res; 1991 Oct; 51(19):5171-6. PubMed ID: 1680546
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.
Kohler MF; Marks JR; Wiseman RW; Jacobs IJ; Davidoff AM; Clarke-Pearson DL; Soper JT; Bast RC; Berchuck A
J Natl Cancer Inst; 1993 Sep; 85(18):1513-9. PubMed ID: 8360934
[TBL] [Abstract][Full Text] [Related]
8. p53 expression, mutation, and allelic deletion in ovarian cancer.
McManus DT; Yap EP; Maxwell P; Russell SE; Toner PG; McGee JO
J Pathol; 1994 Nov; 174(3):159-68. PubMed ID: 7823248
[TBL] [Abstract][Full Text] [Related]
9. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
10. p53 mutation is a common genetic event in ovarian carcinoma.
Milner BJ; Allan LA; Eccles DM; Kitchener HC; Leonard RC; Kelly KF; Parkin DE; Haites NE
Cancer Res; 1993 May; 53(9):2128-32. PubMed ID: 8481915
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.
Righetti SC; Della Torre G; Pilotti S; Ménard S; Ottone F; Colnaghi MI; Pierotti MA; Lavarino C; Cornarotti M; Oriana S; Böhm S; Bresciani GL; Spatti G; Zunino F
Cancer Res; 1996 Feb; 56(4):689-93. PubMed ID: 8630996
[TBL] [Abstract][Full Text] [Related]
13. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
14. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
[TBL] [Abstract][Full Text] [Related]
15. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line.
Chow VT; Quek HH; Tock EP
Cancer Lett; 1993 Sep; 73(2-3):141-8. PubMed ID: 8221626
[TBL] [Abstract][Full Text] [Related]
17. Multiplex PCR (MPCR) Screening Can Detect Small Intragenic p53 Deletion and Insertion Mutations.
Runnebaum IB; Wang-Gohrke S
Methods Mol Med; 2001; 39():329-35. PubMed ID: 21340788
[TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations and protein accumulation in human ovarian cancer.
Kupryjańczyk J; Thor AD; Beauchamp R; Merritt V; Edgerton SM; Bell DA; Yandell DW
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4961-5. PubMed ID: 8506342
[TBL] [Abstract][Full Text] [Related]
19. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
[TBL] [Abstract][Full Text] [Related]
20. Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?
Yamada R; Maeda N; Oguri H; Adachi Y; Takeuchi T; Furihata M; Fukaya T
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):96-100. PubMed ID: 24017961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
